Literature DB >> 10189266

Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions.

N B Bam1, J L Cleland, J Yang, M C Manning, J F Carpenter, R F Kelley, T W Randolph.   

Abstract

In the absence of surfactants, recombinant human growth hormone (rhGH) rapidly forms insoluble aggregates during agitation. The nonionic surfactant Tween 20, when present at Tween:protein molar ratios >4, effectively inhibits this aggregation. Differential scanning calorimetry (DSC) of rhGH solutions showed melting transitions that decreased by ca. 2 degrees C in the presence of Tween. Circular dichroism (CD) studies of the same thermal transition showed that the decrease is specific to the relatively high protein concentrations required for DSC. CD studies showed melting transitions that decreased with lower protein concentrations. Tween has an insignificant effect on the melting transition of rhGH at lower protein concentrations (0.18 mg/mL). Injection titration microcalorimetry showed that the interaction of Tween with rhGH is characterized by a weak enthalpy of binding. For comparison, interferon-g, another protein which has been shown to bind Tween, also shows weak enthalpy of binding. Fluorescent probe binding studies and infrared spectroscopic investigations of rhGH secondary structure support suggestions in the literature (Bam, N. B.; Cleland, J. L., Randolph, T. W. Molten globule intermediate of recombinant human growth hormone: stabilization with surfactants. Biotechnol. Prog. 1996. 12, 801-809) that Tween binding is driven by hydrophobic interactions, with little perturbation of protein secondary structure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10189266     DOI: 10.1021/js980175v

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  37 in total

1.  Inverse relationship of protein concentration and aggregation.

Authors:  Michael J Treuheit; Andrew A Kosky; David N Brems
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  High pressure fosters protein refolding from aggregates at high concentrations.

Authors:  R J St John; J F Carpenter; T W Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 3.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

4.  Stabilizing peptide fusion for solving the stability and solubility problems of therapeutic proteins.

Authors:  Eui Nam Lee; Young Mok Kim; Hye Ja Lee; Sang Woo Park; Han Young Jung; Jae Myun Lee; Yong-Ho Ahn; Jongsun Kim
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

5.  The effect of stabilizers and denaturants on the cold denaturation temperatures of proteins and implications for freeze-drying.

Authors:  Xiaolin Charlie Tang; Michael J Pikal
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

6.  Displacement of adsorbed insulin by Tween 80 monitored using total internal reflection fluorescence and ellipsometry.

Authors:  S H Mollmann; U Elofsson; J T Bukrinsky; S Frokjaer
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

7.  Aggregation of recombinant human interferon alpha 2b in solution: technical note.

Authors:  Llamil Ruiz; Kethia Aroche; Nuria Reyes
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

8.  Insights into protein-polysorbate interactions analysed by means of isothermal titration and differential scanning calorimetry.

Authors:  Claudia Hoffmann; Alfred Blume; Inge Miller; Patrick Garidel
Journal:  Eur Biophys J       Date:  2009-02-03       Impact factor: 1.733

Review 9.  Considerations for the Use of Polysorbates in Biopharmaceuticals.

Authors:  Michael T Jones; Hanns-Christian Mahler; Sandeep Yadav; Dilbir Bindra; Vincent Corvari; R Matthew Fesinmeyer; Kapil Gupta; Alexander M Harmon; Kenneth D Hinds; Atanas Koulov; Wei Liu; Kevin Maloney; John Wang; Ping Y Yeh; Satish K Singh
Journal:  Pharm Res       Date:  2018-05-24       Impact factor: 4.200

10.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.